CircCRIM1 has been reported to promote nasopharyngeal carcinoma (NPC) metastasis and docetaxel chemoresistance via serving as a ceRNA against miR-422a to improve the FOXQ1 level (Hong et al., 2020). This evidence concerns the gene FOXQ1 and nasopharyngeal carcinoma.